Curriculum Vitae

PROF. DR. CHEE KOK HAN

Professor
  • Department of Medicine
    Faculty of Medicine
  • cheekh
  • 0176952750

ACADEMIC QUALIFICATION

  • MMED(2002) (UM), (Internal Medicine)
    Universiti Malaya (UM)
  • MBBS(1995) (UM), (Medicine and Surgery)
    Universiti Malaya (UM)

ADMINISTRATIVE DUTIES

  • Head coordinator Primary PCI for STEMI Klang GH-UMMC
    01 Jul 2015 - present (National)
  • Head Coordinator
    18 Feb 2013 - present (Department of Medicine, Faculty of Medicine)
  • Member of Master Part 1 Exam Question Vetting Committee
    01 Jan 2013 - 31 Dec 2015 (National)
  • Acting Head of Department
    20 Sep 2015 - 26 Sep 2015 (University Malaya)

MEMBERSHIPS

  • ASEAN FEDERATION OF COLLEGE OF CARDIOLOGY, MEMBER
    Since 2016 (International)
  • AMERICAN COLLEGE OF CARDIOLOGY, MEMBER
    Since 2016 (International)
  • EUROPEAN SOCIETY OF CARDIOLOGY, MEMBER
    Since 2011 (International)
  • NATIONAL HEART ASSOCIATION OF MALAYSIA, MEMBER
    Since 2008 (National)
  • NATIONAL HEART ASSOCIATION MALAYSIA, COUNCIL MEMBER
    2018 to 2020 (National)

AWARD AND STEWARDSHIP

  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2014 (University)

PUBLICATIONS

Article in Journal
  1. Tan P.J., Khoo E.M., Chinna K., Saedon N.I., Zakaria M.I., Zahedi A.Z.A., Ramli N., Khalidin N., Mazlan M., Chee K.H., Abidin I.Z., Nalathamby N., Mat S., Jaafar M.H., Khor H.M., Khannas N.M., Majid L.A., Tan K.M., Chin A.-V., Kamaruzzaman S.B., Poi P., Morgan K., Hill K.D., MacKenzie L., Tan M.P. 2018. Individually-tailored multifactorial intervention to reduce falls in the Malaysian Falls Assessment and Intervention Trial (MyFAIT): A randomized controlled trial. PLoS ONE
  2. Tan, L. K., Liew, Y. M., Lim, E., Abdul Aziz, Y. F., Chee, K. H., & McLaughlin, R. A. (2018). Automatic localization of the left ventricular blood pool centroid in short axis cardiac cine MR images. Medical & Biological Engineering & Computing, 56(6), 1053 1062. https://doi.org/10.1007/s11517-017-1750-7
  3. Tan, S. K., Yeong, C. H., Raja Aman, R. R. A., Ng, K. H., Abdul Aziz, Y. F., Chee, K. H., & Sun, Z. (2018). Low tube voltage prospectively ECG-triggered coronary CT angiography: a systematic review of image quality and radiation dose. The British journal of radiology, 91(xxxx), 20170874
  4. Ageno W1, Casella IB, Han CK, Raskob GE, Schellong S, Schulman S, Singer DE, Kimura K, Tang W, Desch M, Goldhaber SZ. RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate. Thromb Haemost. 2017 Jan 26;117(2):415-421.
  5. Greenlaw, N., & Krishnan, C. (2017). Clinical characteristics, treatment and 2-year outcomes in Malaysian and Bruneian patients with stable coronary artery within the worldwide CLARIFY registry. Med J Malaysia, 72(5), 283.
  6. HT Wong, KH Chee, AW Chong. Pulmonary hypertension and echocardiogram parameters in obstructive sleep apnea. European Archives of Oto-Rhino-Laryngology 274 (6), 2601-2606
  7. Leong, C. O., Liew, Y. M., Bilgen, M., Abdul Aziz, Y. F., Chee, K. H., Chiam, Y. K., & Lim, E. (2017). Assessment of infarct specific cardiac motion dysfunction using modeling and multimodal magnetic resonance merging. Journal of Magnetic Resonance Imaging, 45(2), 525-534.
  8. Yan Ling Yong, Li Kuo Tan, Robert A. McLaughlin, Kok Han Chee, Yih Miin Liew, "Linear-regression convolutional neural network for fully automated coronary lumen segmentation in intravascular optical coherence tomography," Journal of Biomedical Optics 22(12), 126005 (2017), doi: 10.1117/1.JBO.22.12.126005.
  9. Goh, Choon-Hian BBEng; Ng, Siew-Cheok PhD; Kamaruzzaman, Shahrul B. PhD; Chin, Ai-Vyrn MD; Poi, Philip J. H. MRCP; Chee, Kok Han MMED; Imran, Z. Abidin MMED; Tan, Maw Pin MD. Evaluation of Two New Indices of Blood Pressure Variability Using Postural Change in Older Fallers. Medicine KW . 2016;95(19).
  10. Ismail, M. D., Han, C. K., & Loch, A. (2016). Dislodgement of the MGuard Prime MicroNet During Primary PCI. Cardiovascular and interventional radiology, 39(5), 785 787. https://doi.org/10.1007/s00270-015-1290-1
  11. Ganiga Srinivasaiah Sridhar, Muhammad Athar Sadiq, Wan Azman Wan Ahmad, Chitra Supuramaniam, Timothy Watson, Imran Zainal Abidin, and Kok Han Chee. Unruptured Sinus of Valsalva Aneurysm with Right Ventricular Outflow Tract Obstruction and Supracristal Ventricular Septal Defect: A Rare Case. Tex Heart Inst J 2015;42(5):462-4
  12. Goh C-H, Ng S-C, Kamaruzzaman SB, et al. The Evaluation of New Index for Blood Pressure Variability Using Posture Change Among Older Fallers. Journal of Hypertension 2015;33:e3.
  13. Liew Y, McLaughlin R, Chan B, et al. Motion corrected LV quantification based on 3D modelling for improved functional assessment in cardiac MRI. Physics in medicine and biology 2015;60:2715.
  14. Szyuin Sim, Semira A. Beshir1, Kok-Han Chee, Yoke-Lin Lo. 2015. Abstract: Retrospective Analyses of Bleeding Associated with Novel Oral Anticoagulants (NOACs) in Cardiac Patients in UMMC. Malaysian Journal of Pharmacy.2(1):49
  15. Z J, YM L, M B, et al. Regional assessment of LV wall in infarcted heart using tagged MRI and cardiac modelling. Phys Med Biol;60:4015-31.
  16. Ahmad F, Sadiq MA, Chee KH, Mahmood Zuhdi AS, Wan Ahmad WA.Atrial septal defect coexistent with Sj gren's syndrome. J Coll Physicians Surg Pak. 2014 Jun;24(6):441-3. doi: 06.2014/JCPSP.441443.
  17. Chee K, Tan K. Impact of atrial fibrillation among stroke patients in a Malaysian teaching hospital. Med J Malaysia 2014;69:119-23.
  18. Sridhar GS, Sadiq MA, Ahmad WAW, et al. Transient cortical blindness: A benign but devastating complication after coronary angiography and graft study. JPMA The Journal of the Pakistan Medical Association 2014;64:1195-7.
  19. Wan Ab Naim, Wan Naimah, Poo Balan Ganesan, Zhonghua Sun, Kok Han Chee, Shahrul Amry Hashim and Einly Lim. "A Perspective Review on Numerical Simulations of Hemodynamics in Aortic Dissection." The Scientific World Journal 2014, (2014): 12.
  20. Ahmad, W. A., et al. (2013). "The journey of Malaysian NCVD-PCI (National Cardiovascular Disease Database-Percutaneous Coronary Intervention) Registry: a summary of three years report." Int J Cardiol 165(1): 161-164.
  21. Chan BT, Lim E, Chee KH, Abu Osman NA. Review on CFD simulation in heart with dilated cardiomyopathy and myocardial infarction. Computers in biology and medicine 2013;43:377-85.
  22. Chan, Bee Ting, Noor Azuan Abu Osman, Einly Lim, Kok Han Chee, Yang Faridah Abdul Aziz, Amr Al Abed, Nigel H Lovell and Socrates Dokos. "Sensitivity Analysis of Left Ventricle with Dilated Cardiomyopathy in Fluid Structure Simulation." PloS one 8, no. 6 (2013): e67097.
  23. KH Chee. Favourable outcome after peripartum cardiomyopathy: a ten-year study on peripartum cardiomyopathy in a university hospital. Singapore Med J 2013; 54(1): 28 31
  24. Kadirvelu A, Han CK, Heung TK, Choy AM, Rais MM, Choy LC. Role of Endothelial Dysfunction in Cardiovascular Disease: A Review. Journal of Health and Translational Medicine 2012;5.
  25. Ahmad WAW, Ali RM, Zambahari R, et al. Highlights of the first Malaysian National Cardiovascular Disease Database (NCVD): Percutaneous Coronary Intervention (PCI) Registry. CVD Prevention and Control 2011;6:57- 61.
  26. Ahmad, Wan Azman Wan, Rosli Mohd Ali, Mehrunnissa Khanom, Chee Kok Han, Liew Houng Bang, Alan Fong Yean Yip, Azmee Mohd Ghazi, Omar Ismail, Robaayah Zambahari and Sim Kui Hian. "The Journey of Malaysian Ncvd Pci (National Cardiovascular Disease Database Percutaneous Coronary Intervention) Registry: A Summary of Three Years Report." International journal of cardiology 6, (2011): 57-61.
  27. Omar R, Teo WS, Foo D, et al. Atrial Fibrillation in Singapore and Malaysia: Current Trends and Future Prospects. Journal of Arrhythmia 2011;27:171-85
  28. Sadiq, Muhammad Athar. "Transient Cortical Blindness after Coronary Angiography and Graft Study." Pakistan Journal of Medical Sciences 27, no. 4 (2011).
  29. Chee KH, Azman W. Prevalence and outcome of peripartum cardiomyopathy in Malaysia. Int J Clin Pract 2009;63:722-5
  30. Wong MH, Chee KH, Azman W. Symptomatic anaemia 17 years after double valve replacement. Singapore Med J 2009;50:e362-4.
  31. Yaacob, ZH, S Syed Tamin, NH Nik Zainal, KH Chee, WP Chong and NE Hashim. "Ventricular Dyssynchrony Is Common among Heart Failure Patients with Narrow Qrs Complex." Journal of the University of Malaya Medical Centre (JUMMEC) 12, no. 2 (2009): 57-62.
  32. Sim, K. H., et al. (2007). "Need for surveillance of concomitant peripheral artery disease in patients with coronary disease: results of the AGATHA survey in Malaysia." J Geriatr Cardiol 4: 195-199.
  33. Oasis 5 Investigators, Comparison of fondaparinux and enoxaparin in acute coronary syndromes N Engl J Med 2006;354:1464-76.
  34. Chee, KH, FS Siaw, CG Chan, WP Chong, ZA Imran, HK Haizal, W Azman and KH Tan. "Clinical Experience in Coronary Stenting with the Vivant Z Stent." International journal of clinical practice 59, no. 6 (2005): 628-631.
  35. Amudha, K., et al. (2003). "Prevalence of peripheral artery disease in urban high-risk Malaysian patients." Int J Clin Pract 57(5): 369-372.
  36. Chee, Kok H, Kadirvelu Amudha, Nik A Hussain, Haron K Haizal, Anna- Maria J Choy and Chim C Lang. "Combination of Drugs Acting on the Natriuretic System and the Renin-Angiotensin System in Heart Failure." Journal of Renin-Angiotensin-Aldosterone System 4, no. 3 (2003): 140- 148.
  37. Kadirvelu, A, Chee Kok Han and Chim Choy Lang. "Endothelial Dysfunction in Cardiovascular Diseases." Med Prog, (2002): 4-10.
Chapter in Books
  1. Annual report of the NCVD-PCI Registry Year 2010-2012
  2. Ahmad, Wan Azman Wan and Sim Kui-Hian. "Annual Report of the Percutaneous Coronary Intervention (Pci) Registry 2007-2009." (2011).
  3. Chee K-H, Kamar HH. Acute Chest Pain. In: Chan Y-K, Ng K-P, eds. Management aspects of acute care: University Malaya Press; 2006:101-9.
Article in Proceeding
  1. Ko TY Andy, Ang CC, Chee KH, Tai MLS, K Rishi, Tan KS. Atrial fibrillation: A Major contributor to Stroke Severity and poorer outcome in acute ischaemic stroke patients in Malaysia.Cerebrovascular Dis;36(suppl 1):p75)

RESEARCH PROJECT

National
  1. 2009 - 2014, Boehringer Ingelheim Korea Ltd.
    RELY-ABLE : Long term multi-center extension of Dabigatran treatment in patients with atrial fibrillation who completed the RE- LY trial and a cluster randomised trial to assess the effect of a knowledge translation intervention on patient outcomes. ( Principal Investigator(PI))
  2. 2008 - 2010, Bristol-Myers Squib
    Apixaban versus Acetylsalicyclic Acid (ASA) to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for Vitamin K antagonist treatment: A Randomized Double Blind Trial. ( Principal Investigator(PI))
International
  1. 2013 - 2016, Merck Sharp & Dohme (M) Sdn. Bhd
    A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes Mellitus ( Principal Investigator(PI))
  2. 2013 - 2016, Institut de Recherches Internationales Servier (I.R.I.S)
    Effects of ivabradine on plaque burden, morphology and composition in patients with clinically indicated coronary angiography. A randomised double-blind placebo-controlled international multicenter study. (MODIFY) ( Principal Investigator(PI))
  3. 2013 - 2014, F. Hoffman-La Roche Ltd
    A Phase 3B Study to Evaluate the Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients with Stable Cardiovascular Disease and Glucose Abnormalities ( Principal Investigator(PI))
  4. 2007 - 2014, Merck Sharp & Dohme (M) Sdn. Bhd
    A Multicentre, Randomized, Double-blind, Parallel Arm, 6-week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin versus Atorvastatin In Patients With Metabolic Syndrome And Hypercholesterolemia At High Risk for Coronary Heart Disease. ( Principal Investigator(PI))
  5. 2008 - 2013, Merck Sharp & Dohme (M) Sdn. Bhd
    A 76-week, worldwide, multicenter, double-blind, randomized, placebo-controlled study to assess the tolerability and efficacy of anacetrapid when added to ongoing therapy with a statin in patients with hypercholesterolemia or mixed hyperlipidemia. ( Principal Investigator(PI))
  6. 2010 - 2012, Astellas Pharma Inc
    A Randomised, Double-Blind, Placebo Controlled Multi-Center and Parallel Group Study of The Safety, Tolerability and Efficacy of YM150 in Combination With Standard Treatment in Secondary Prevention of Ischemic Vascular Events in Subjects with Acute Coronary Syndromes. ( Principal Investigator(PI))
  7. 2010 - 2012, Boehringer Ingelheim
    A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10mg and 25mg administered orally once daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients With Increased Cardiovascular Risk. ( Principal Investigator(PI))
  8. 2008 - 2012, Schering Plough Research Institute
    A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of SCH 530348 in addition to standard of care in subjects with acute coronary syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome. ( Principal Investigator(PI))
  9. 2008 - 2012, Schering Plough Research Institute
    A Multicentre, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events. ( Principal Investigator(PI))
  10. 2010 - 2011, Sanofi-Aventis (M) Sdn. Bhd
    A Randomized, Double Blind, Placebo Controlled, Parallel Group Trial for Assessing the Clinical Benefit of Dronedarone 400mg BID on Top of Standard Therapy in Patients with Permanent Atrial Fibrillation and Additional Risk Factors. ( Principal Investigator(PI))
  11. 2006 - 2009, Boehringer Ingelheim
    Randomized Evaluation of Long Term Anticoagulated Therapy (RE- LY) Comparing the Efficacy and Safety Of Two Blinded Doses of Debigatran Etexilate with Open Label Warfarin For The Prevention Of Stroke And Systemic Embolism In Patients With Non-Valvular Atrial Fibrillation: Prospective, Multi-Centre, Parallel-Group, Non- Inferiority Trial. ( Principal Investigator(PI))
  12. 2005 - 2007, Sanofi-Aventis (M) Sdn. Bhd
    A placebo-controlled double-blind, parallel arm trial to assess the efficacy of dronedarone 400mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation / atrial flutter. ( Principal Investigator(PI))
  13. 2005 - 2007, Schering Plough Research Institute
    Early Glycoprotein IIb/IIIa Inhibition in Non-ST- segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients With Non-ST-segment Elevaluation Acute Coronary Syndrome. ( Principal Investigator(PI))

CONSULTANCY PROJECT

  • Steering for Recovery Ii International Research, Boehringer Ingelheim Canada Ltd.
    01 Mar 2015 - 01 Mar 2018 (International)
  • Boehringer Ingelheim Advisory Board Meeting Stroke Prevention in Atrial Fibrillation, Boeringer Ingelheim
    01 Nov 2016 - 01 Nov 2016 (International)
  • 1st Southeast Asia & South Korea Cv Emphasis Advisory Board, Boehringer Ingelheim South East Asia & Korea
    01 Dec 2015 - 01 Dec 2015 (International)
  • Spaf Asia Regional Advisory Board, Pfizer International Limited
    01 Nov 2015 - 01 Nov 2015 (International)
  • Jardiance Advisory Board, Boehringer Ingelheim (Malaysia) Sdn Bhd
    01 Sep 2015 - 01 Sep 2015 (National)

PAPER PRESENTED

PLENARY SPEAKER
  1. OpImal Dual AnIplatelet Treatment DuraIon post DES stents in ACS PaIents, 22nd ASEAN Federation of Cardiology Congress, ASEAN Federation of Cardiology (International) (03 Nov 2017 - 05 Nov 2017)
  2. Oral Anticoagulant + Specific Reversal = More Control : Where are we heading?, National Heart Association of Malaysia Annual Scientific Meeting, National Heart Association of Malaysia (International) (07 Apr 2017 - 09 Apr 2017)
  3. ACS Management with oral anti platelet, what is new in ACC 2016?, Penang Cardiovascular Conference, Penang Medical Education (National) (05 Nov 2016 - 06 Nov 2016)
  4. Anticoagulation 3.0, Penang Cardiovascular Conference, Penang Medical Education (National) (05 Nov 2016 - 06 Nov 2016)
  5. The EMPA-REG OUTCOME trial: Outcomes in the heart, Expert exchange in Cardio Metabolic, Boehringer Ingelheim (National) (03 Sep 2016 - 03 Sep 2016)
  6. Cardiovascular Risk and Type 2 Diabetes: Why do we Care About CV Outcomes in T2D?, Expert exchange in Cardio Metabolic, Boehringer Ingelheim (National) (03 Sep 2016 - 03 Sep 2016)
  7. Starting Apixaban in Patients with AF, Battle of the scientific data II, Pfizer Sdn Bhd (National) (24 Oct 2015 - 25 Oct 2015)
  8. Peri-procedural management of NOAC, Battle of the scientific data II, Pfizer Sdn Bhd (National) (24 Oct 2015 - 25 Oct 2015)
  9. Diagnosis approach of deep vein thrombosis & pulmonary embolism, Battle of the scientific data II, Pfizer Sdn Bhd (National) (24 Oct 2015 - 25 Oct 2015)
  10. Managing NVAF after patient had a stroke, Battle of the scientific data II, Pfizer Sdn Bhd (National) (24 Oct 2015 - 25 Oct 2015)
  11. IMPROVE-IT On treatment analysis results, IMPROVE-IT Closed Research Update, National Heart Association of Malaysia (National) (14 Dec 2014 - 14 Dec 2014)
  12. Plenary symposium 4: Change of landscape in the treatment of acute coronary syndrome, Penang Cardiovascular Conference 2013 (National) (28 Sep 2013 - 29 Sep 2013)
  13. Insights into cost effectiveness data, South East Asia stroke prevention in atrial fibrillation (International) (21 Sep 2013 - 21 Sep 2013)
  14. Dabigatran etexilate for prevention of atrial fibrillation-related strokes: a cardiologist s perspective (2), South East Asia stroke prevention in atrial fibrillation (International) (21 Sep 2013 - 21 Sep 2013)
  15. Translating clinical trial results into practice, South East Asia Stroke prevention in atrial fibrillation forum (International) (21 Sep 2013 - 21 Sep 2013)
INVITED SPEAKER
  1. AICD for primary prevenIon in non-ischaemic cardiomyopathy, 22nd ASEAN Federation of Cardiology Congress, ASEAN Federation of Cardiology (International) (03 Nov 2017 - 05 Nov 2017)
  2. Subtle ECGs which are deadly and commonly missed- How to identify, 10th Asia Pacific CardiologyUpdate@USM 2017, University Science Malaysia (International) (20 Oct 2017 - 22 Oct 2017)
  3. Patients with palpitations and near syncope-Systematic Approach on tachyarrhythmmia, 10th Asia Pacific CardiologyUpdate@USM 2017, University Science Malaysia (International) (20 Oct 2017 - 22 Oct 2017)
  4. Role of reversal agents, REVERSE AD and real life experience with idarucizumab, 21st Asian Pacific Society of Cardiology Congress, Asian Pacific Society of Cardiology Congress (International) (14 Jul 2017 - 14 Jul 2017)
  5. Is cardiovascular disease an inevitable outcome of T2D?, ACROSS T2D Scientific Exchange Meeting, Boehringer Ingelheim (National) (22 Apr 2017 - 22 Apr 2017)
  6. HF outcome in T2D focus on Empa-Reg Outcome, Asian CardioDiabetes Forum 2017, Boeringer Ingelheim (International) (25 Feb 2017 - 26 Feb 2017)
  7. Case presentation, Guangxi Coronary Intervention Forum, Asian Society of Cardiology (International) (19 Nov 2016 - 19 Nov 2016)
  8. Cardio protection in diabetes mellitus, Inside out: Managing diabetes workshop, PPUM Diabetes Care Unit (National) (09 Oct 2016 - 09 Oct 2016)
  9. Secondary prevention, Malaysia Diabetes Educators Society Conference 2016, Malaysia Diabetes Educators Society (International) (22 Apr 2016 - 23 Apr 2016)
  10. Heart failure in Pregnancy, National Heart Association of Malaysia Annual Scientific Meeting, National Heart Association of Malaysia (International) (08 Apr 2016 - 10 Apr 2016)
  11. RealWorld:StrokePrevention in Practice, National Heart Association Malaysia Annual Scientific Meeting, National Heart Association Malaysia (08 Apr 2016 - 10 Apr 2016)
  12. NOACs: Dosage optimizationand peri-operative / peri-PCI management, National Heart Association Malaysia Annual Scientific Meeting, National Heart Association Malaysia (International) (08 Apr 2016 - 10 Apr 2016)
  13. Epidemiology / Overview / Introduction, Pulmonary Hypertension Workshop (National) (30 Jan 2016 - 30 Jan 2016)
  14. Case Studies : Cardiology, Pulmonary Hypertension Workshop (National) (30 Jan 2016 - 30 Jan 2016)
  15. Classification / Diagnostic Workup, Pulmonary Hypertension Workshop (National) (30 Jan 2016 - 30 Jan 2016)
  16. When Hypertensive Patients Have AF: What to do?, 13th Annual Scientific Meeting of the Malaysia Society of Hypertension, Malaysian Society of Hypertension (International) (15 Jan 2016 - 17 Jan 2016)
  17. Management AF patients with STEMI & Anticoagulation 3.0 , Lumen Global 2016, Lumen Global (International) (09 Jan 2016 - 10 Jan 2016)
  18. EMPA-Reg Outcome, Cardiovascular Risk & Type 2 Diabetes, Boeringer Ingeheim (International) (11 Dec 2015 - 11 Dec 2015)
  19. EMPA-REG Outcome The Outcomes, SGLT2 Inhibitor Speaker Forum, Boeringer Ingeheim (National) (15 Nov 2015 - 15 Nov 2015)
  20. EMPA-REG Outcome - Design and Population, SGLT2 Inhibitor Speaker Forum , Boeringer Ingeheim (National) (15 Nov 2015 - 15 Nov 2015)
  21. Management of ACS in Diabetes Mellitus, Diabetes complication workshop, Endocrinology Unit, UMMC (University) (06 Sep 2015 - 06 Sep 2015)
  22. VTE & PE treatment, 9th SPAF Forum: Innovation in anticoagulation care, Boeringer Ingeheim (National) (01 Aug 2015 - 01 Aug 2015)
  23. Providing optimal care for our DVT/PE patients, 9th SPAF Forum: Innovation in Anticoagulation Care, Boeringer Ingeheim (National) (01 Aug 2015 - 01 Aug 2015)
  24. Navigating the evidence - Are all NOACs the same?, Continuing Medical Education, Queen Elizabeth Hospital (Others) (29 Jul 2015 - 29 Jul 2015)
  25. IMPROVE-IT, the lower the better, CME at Bahagian Farmasi, Biro Pengawalan Farmaseutikal Kebangsaan, Bahagian Farmasi, Biro Pengawalan Farmaseutikal Kebangsaan (Others) (08 Jul 2015 - 08 Jul 2015)
  26. Beyond BP, Beats count, Merck GP Workshop 2015, Merck Serono Kuala Lumpur (Others) (14 Jun 2015 - 14 Jun 2015)
  27. How do I treat?, My LIVE 2015, National Heart Association Malaysia (National) (11 Jun 2015 - 13 Sep 2015)
  28. Overview of dabigatran for stroke prevention in AF & Asian perspective, SPAF Forum National Heart Centre, Singapore, National Heart Centre Singapore (International) (23 May 2015 - 23 May 2015)
  29. Updates in cardiovascular medicine, 9th Asean Conference on Primary Health Care, Perak Medical Practioner's Society (International) (24 Apr 2015 - 26 Apr 2015)
  30. Practical Insights for Patient Management in Primary Care, Singapore Cardiac Society Annual Scientific Meeting, Singapore Cardiac Society (International) (19 Apr 2015 - 19 Apr 2015)
  31. Native and Artificial Valvular Heart Disease in Pregnancy, 1st Serdang Heart Disease in Pregnancy Symposium, Serdang General Hospital (National) (18 Apr 2015 - 18 Apr 2015)
  32. Considering the bigger the picture: Practical Insights for Patient Management, Lunch Symposium at National Heart Association Malaysia 2015 Annual Scientific Meeting, Boehringer Ingelheim (International) (11 Apr 2015 - 11 Apr 2015)
  33. Pregnancy and heart disease, when should I refer?, NHAM Annual Scientific Meeting 2015 , National Heart Association Malaysia (International) (09 Apr 2015 - 11 Apr 2015)
  34. Peripartum cardiomyopathy: an update, NHAM Annual Scientific Meeting 2015, National Heart Association Malaysia (International) (09 Apr 2015 - 11 Apr 2015)
  35. Role of Primary Care In Managing Hypertension: What can we learn from Real Life Study (EXCITE trial), Malaysia Society of Hypertension Annual Scientific Meeting, Malaysian Society of Hypertension (National) (23 Jan 2015 - 25 Jan 2015)
  36. Hypertension and atrial fibrillation: Is it the rate or the rhythm?, Malaysian Society of Hypertension Annual Scientific Meeting, Malaysian Society of Hypertension (National) (23 Jan 2015 - 25 Jan 2015)
  37. Why does stroke prevention in AF patients matter in Asian? A cardiologist's perspective, 19th Hong Kong Medical Forum (International) (03 May 2014 - 04 May 2014)
  38. The role of NOACs in Stroke prevention in Atrial fibrillation, 2nd National Venous Thromboembolism Congress 2013, Jabatan Perubatan Hospital Serdang (National) (12 Sep 2013 - 13 Sep 2013)
  39. Understanding key clinical insights a) Appropriate use in different patient groups, SPAF Forum National Heart Centre Singapore, National Heart Centre Singapre (International) (  - 23 May 2015)
EVENT ORGANISER
  1. Debate: All NOACs are the same, Battle of the scientific II, Pfizer Sdn Bhd (National) (24 Oct 2015 - 25 Oct 2015)
  2. Cardiac rhythm devices: a brief introduction, 2nd Beginner course on Pacemaker & ICD, Cardiology Unit, UMMC (National) (10 Oct 2015 - 10 Oct 2015)
POSTER PRESENTER
  1. A Retrospective Review of Appropriate and Inappropriate Therapies among Patients with Implanted Cardiac Defibrillator in a University Hospital, Asian Pacific Society of Cardiology 2013 Congress, Asian Pacific Society of Cardiology (International) (22 Feb 2013 - 24 Feb 2013)
OTHERS
  1. Live session II: ACS, My LIVE 2015, National Heart Association Malaysia (National) (11 Jun 2015 - 13 Jun 2015)
  2. A diabetic patient with chest pain: how would I manage?, NHAM Annual Scientific Meeting 2015, National Heart Association Malaysia (International) (09 Apr 2015 - 11 Apr 2015)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2013) Macedonian Journal of Medical Sciences, (Reviewer)
  2. (2013) Malaysian Journal of Medical Sciences, (Reviewer)
  3. (2008) Malaysia Family Physician Journal, (Reviewer)
Contribution to external organisation
  1. (2015) International Disease Registry, European registry of pregnancy and cardiac disease, International
  2. (2013) International Disease Registry, Peripartum Cardiomyopathy (PPCM) Registry of the EURObservational Research Programm, International
  3. (2013) develop practical engineering solutions to cardiovascular problems, which will improve patient quality of life and health care outcomes., Asian Cardiac Engineering laboratory
  4. (2011) UMMC/Quintiles Joint Executive Steering Committee (JESC), Joint Executive Steering Committee (JESC)
Contribution to event
  1. (2021) Invited Speaker : Culprit Vs Complete Revascularization - Real World Practice, International, (Panelist/Moderator)
  2. (2021) Panelist for Complex Pci Management : Delivering What Matters, International, (Panelist/Moderator)

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2009) microRNA in cardiovascular disease, Jocelyn Soh Zi Ling
Master
  1. (2009) Cardiology Fellow Training, Dr Sridhar Ganiga Srinivasaiah
  2. (2008) Cardiology Fellow Training, Ang Choon Chin
Under Graduate Students
  1. (2009) The hypertensive control in diabetes patient and the regime used according to the guideline

TEACHING

Bachelor
  1. (2014) Clinical Days

SOCIAL RESPONSIBILITY ACTIVITIES

  • Education to Public About Prevalence of Heart Disease in Malaysia, (10 Aug 2017 - 10 Aug 2017)
  • World Heart Day Special Program On Ntv7, (01 Oct 2015 - 01 Oct 2015)